Background and D esign: Disorders of keratiniza tion are a heterogeneous group of diseases that have in common a defect in cornification. The bioactive form of vitamin D3 has been shown to modulate epidermal pro liferation and differentiation. The purpose of the pres ent study was to determine the effect of the synthetic vi tamin D3 calcipotriol in a randomized, double-blind, placebo-controlled, right/left comparative study. The 67 patients included in the study were at least 12 years of age and had the following diseases: ichthyosis vulgaris (n=9), X-linked ichthyosis (n=8), congenital ichthyosis (n=10), hereditary palmoplantar keratoderma (n=20), keratosis pilaris (n=9), and Darier's disease (n = ll). Cal cipotriol ointment (50 fxg/g) and placebo (vehicle of cal cipotriol ointment) were applied to all patients twice daily for up to 12 weeks. The patients were allowed to use up to 120 g of calcipotriol ointment per week.
thyoses, although to a variable degree. No therapeutic ef fect was detected in palmoplantar keratoderma or kera tosis pilaris. Eight of 12 patients with Darier's disease had to be withdrawn because of skin irritation or a worsening of the disease. Skin irritation occurred in 18 cases (26%) only on the calcipotriol-treated side, and in one case (1%) only on the placebo-treated side. Nine cases (13%) had irritation on both sides. The amount of calcipotriol oint ment used per week was lowest in palmoplantar kerato derma (mean, 11.8 g/wk; range, 2.1 to 25.6 g/wk) and high est in congenital ichthyosis (mean, 59.3 g/wk; range, 11.4 to 94.7 g/wk). There was no clinically significant change of serum calcium levels during the treatment period.
Conclusion: Short-term treatment with calcipotriol oint ment (50 (xg/g) used in amounts up to about 100 g/wk is moderately efficacious, well-tolerated, and safe in adult patients with various ichthyoses. (Arch Dermatol. 1995; 131:556-560) 1SORDERS OF keratinizamechanisms involve disordered keratinol tion comprise a hetero-cyte differentiation and/or proliferation, geneous group of dis-In addition to the epidermal changes, some eases characterized by dry of the disorders show dermal inflammaancl scaly skin.1 They in-tion and immunologic changes. The bioclude the ichthyoses, Darier's disease, pity-logically active form of vitamin D:J, 1,25riasis rubra pilaris, keratodermas, and fol-d i h y d r o x y v i t a m i n D 3, h as b e e n licular k erato ses. The d iso rd e rs of demonstrated to stimulate the terminal difkeratinization are chronic, often inher-ferentiation of epidermal keratinocytes and ited, diseases with onset in childhood. Treatment is often unsatisfactory, al to inhibit the proliferation of epidermal keratin o cy tes.3 At least in vitro 1,25though lubrication with ointm ents or dihydroxyvitamin D3 modifies differencreams may soften the skin, and topical preparations containing salicylic acid may tiation by stim ulating the sw itch of suprabasal cells into cornified cells.4 Apremove the scaling. In some of the disor-parently, 1,25-dihydroxyvitamin D3 inders, retinoids administered topically, but mainly systemically, are effective.2 Be-duces terminal differentiation of epider mal keratinocytes without changing their cause of the associated risk of severe side keratin gene expression in vitro.5 By modieffects, the systemic retinoids are only used in severe and widespread cases.
Although the disorders of keratini zation are a heterogeneous group of dis eases, they have in common a defect in cor nification. The underlying pathogenic
PATIENTS AND METHODS

PATIENT OUTCOMES
STUDY DESIGN A N D PATIENTS
Clinical assessments were done separately at weeks 0, 2, 4, 8, and 12 for the right and left sides of the body. The extent of the dyskeratotic involvement was recorded using the fol-The study was d esig n ed as a p rosp ective, random ized, lowing scale: 0, no involvement; 1, less than 20%; 2, 20% to double-blind, right/left com parative study of calcipotriol 39%; 3,40% to 59%; 4,60% to 79%; and 5,80% to 100% for (50 (xg/g) and placebo ointm ent (vehicle of calcipotriol oint m ent), both applied tw ice daily. The ingredients of the arms following vehicle were disodium hydrogen phosphate, polyoxyeth-in ichthyosis vulgaris and keratosis pilaris, scales and roughylene-2-stearylether, propylene glycol, tetracemine disohyper clium, DL-a-tocopherol, petrolatum, liquid paraffin, and wa-pigmentation; in Darter's disease, scales, erythema, papules, ter. The study was conducted in two centers in Denm ark crust, and excoriation; in pityriasis rubra pilaris, scales, tliickancl in one center in the N etherlands. Patients w ere not ness, and erythema; in hereditary palmoplantar keratotreated during summertime. The study was divided into two derma, scales, thickness, erythema, and Assuring; and in conphases. After a w ashout phase of 2 w eeks during w hich the genital ichthyosis, scales, roughness, and erythema. These signs patient used only an em ollien t, the patients were given were assessed using the following scale: 0, absent; 1, slight; double-blind treatment w ith calcipotriol ointm ent o n one 2, moderate; and 3, severe. Furthermore, the investigator asside of the body and placebo ointm ent on the other side sessed the overall response to the treatment compared with for 12 w eeks or until clearance on one side. The criterion baseline using the following 6-point scale: worse, no change, for including patients was a clinical and histologic cliag-slight improvement, moderate improvement, marked imnosis of one of the follow ing dyskeratoses: ichthyosis vul-provement, and cleared. The patients assessed the overall regaris, X-linked ichthyosis, congenital ichthyosis, Darier's spouse to treatment using the same scale. Blood samples for disease, pityriasis rubra pilaris, hereditary palmoplantar kera-hematology and blood chemistry analyses, including serum toderma, and keratosis pilaris. The diagnosis of X-linked total calcium levels, were taken before the start of treatment, ichthyosis was based on an established human steroid sulfatase deficiency.111
Patients had sym m etrically located lesions and were at least 12 years of age. E xcluded were patients w ith skin infection; atopic dermatitis; and system ic treatment with retinoids, corticosteroids, or PUVA w ithin the 8-w eek pe riod prior to the w ashout phase. Also excluded w ere pa tients w ith hypercalcem ia, high vitam in D or calcium in-after 2 weeks' treatment, and at the end of treatment. For adverse events the number of patients reporting adverse events on the calcipotriol-treated side only was com pared with the number of patients reporting adverse events on the placebo-treated side only by binomial tests.
STATISTICAL ANALYSIS
Comparison of treatment effects at the end of the double blind treatment period was based on intrapatient variations
All statistical tests were two sided, and a 5% signifi cance level was used. Calcipotriol is a synthetic vitamin D analogue that Sixty-nine patients were randomized to receive treat ies as effective as 1,25-dihydroxyvitamin D* in binding to ment (Table 1 ). However, one patient included in the the vitamin D receptor and in stimulating epidermal dif-Darier's disease group had Hailey-Hailey disease. Furferentiation." Compared with 1,25-dihydroxyvitamin D:Ji thermore, one patient with lamellar ichthyosis left the calcipotriol, however, is about 100 to 200 times less po-study before any collection of efficacy or safety data. There-________ __________________ in rats.8 In clini-fore, efficacy and safety data were only available for 67 cal studies, calcipotriol ointment (50 (xg/g) has been patients. The subgroup of hereditary palmoplantar kerashown to be effective and safe for the treatment of pso-toderma had 20 patients randomized, while the other 'nt in its eliect on ce riasis vulgaris.0 The purpose ; present s groups consisted of eight to 12 patients each. The sub-group of congenital ichthyosis was heterogeneous, con sisting of one patient with epiclermolytic hyperkeratosis (bullous ichthyosiform erythroderma of Brocq, autosomally dominantly inherited), two patients with lamellar ichthyosis (nonerythrodermic autosomal recessive la mellar ichthyosis), two patients with Sjogren-Larsson syn drome, one patient with ichthyosis linearis circumflexa, two patients with congenital ichthyosiform erythro derma (erythrodermic autosomal recessive lamellar ich thyosis) , and two patients with ichthyosis bullosa of Siemens. No case of pityriasis rubra pilaris was random ized., At baseline there was no clinically significant dif ference in the total sign score on the right and left sides (data not shown). Fifteen of the 69 randomized patients withdrew from the double-blind treatment regimen ( Table 2 ). Adverse events were the reason for with drawal in nine of 15 cases (see below). It was remark- able that seven of 12 patients with Darier's disease with drew because of lesional-perilesional irritation or worsening of the disease. In accordance with the high number of withdrawals, the mean duration of doubleblind treatment was only 6.1 weeks in Darier's disease, compared with 9.6 to 12,3 weeks in the other sub groups. Table 3 shows the investigator's overall assess ment of the treatment response to calcipotriol and pla cebo at the end of treatment. Marked improvement or clearance was observed on the calcipotriol-treatecl side in five of nine cases with ichthyosis vulgaris, in four of eight patients with X-linkecl ichthyosis, and in eight of 10 cases with congenital ichthyosis, but the difference between calcipotriol and placebo was only statistically significant for X-linkecl ichthyosis (P=.03) and congeni tal ichthyosis (P=.02). The patient's overall assessment at the end of the treatment period is tabulated in the same way (Table 4 ). According to the patients, marked im provement or clearance was observed on the calcipotrioltreated side in four of nine patients with ichthyosis vul garis, in four of eight patients with X-linked ichthyosis, and in seven of 10 patients with congenital ichthyosis.
Only in X-linked ichthyosis did the difference between calcipotriol and placebo reach statistical significance (P=.03). The total sign score, defined as the sum of the se verity scores for each side of the body, could have a mini mum range of 0 to 6 for ichthyosis vulgaris and kerato sis pilaris and a maximum range from 0 to 15 for Darier's disease. The decrease in the total sign score at the end of the treatment period was greater on the calcipotrioltreated side than on the placebo-treated side in ichthyo sis vulgaris, X-linked ichthyosis, and congenital ichthyo sis (Figure) In congenital ichthyosis this reduction in the total sign score on the calcipotriol-treated side was statistically highly significant compared with the placebotreated side (P=.0015) (Figure) . There was no statisti cally significant difference between calcipotriol and pla cebo in the mean total sign score or overall assessment in other subgroups of dyskeratosis (data not shown).
The adverse events reported or observed during the treatment period were almost exclusively localized to the skin and consisted almost exclusively of various forms of lesional and perilesional irritation (Table 5 ). No ir ritation was detected in congenital ichthyosis. Lesionalperilesional irritation was more often seen on the calci potriol-treatecl side (PC.001). Skin irritation was most common in X-linked ichthyosis and Darier's disease. While only a single patient with X-linked ichthyosis was withdrawn because of skin irritation, six patients with D a rie r's disease w ithdrew because of lesionalperilesional irritation. The amount of calcipotriol oint ment used per week was lowest in palmoplantar kerato- 1 (1 ) 9 derma (mean, 11.8 g/wk; range, 2.1 to 25.6 g/wk) and highest in congenital ichthyosis (mean, 59.3 g/wk; range, 11.4 to 94.7 g/wk). With respect to the change in the se rum total calcium level from baseline to the end of the treatment period, the subgroup X-linked ichthyosis showed a minor, but statistically significant, reduction (P=.045). No subgroup showed any statistically signifi cant increase in the serum total calcium level (data not shown). COMMENT The results of the present study indicate that topical treatwith forms of ichthyosis toderma and keratosis pilaris seem to be unresponsive to calcipotriol, whereas Darier's disease may worsen dur ing treatment with calcipotriol, probably due to the ir ritating capacity of calcipotriol ointment. The presence of eroded and fissured lesions in Darier's disease maybe the reason for the increased susceptibility to become ir ritated by calcipotriol ointment. Except for Darier's dis ease, the cutaneous side effects in the dyskeratotic dis orders were similar to those observed in psoriasis with respect to their nature, severity, and frequency.9 Among the ichthyoses, X-linked ichthyosis and congenital ich thyosis were particularly responsive to calcipotriol. The group with congenital ichthyosis is very heterogeneous, and the low number of patients in each subtype does not allow any conclusions as to any variation in the respon siveness to calcipotriol. In contrast to calcipotriol, nei ther oral la-hydroxyvitamin D36 nor topical 1,25-ARCH DERMATOL/VOL 131, MAY 1995
